Surgical Duration Impacts Venous Thromboembolism Risk in Microsurgical Breast Reconstruction

Abstract

Background Increased surgical duration can impact patient outcomes and operative efficiency metrics. In particular, there are studies suggesting that increased surgical duration can increase the risk of venous thromboembolism (VTE). One of the longer duration plastic surgery procedures commonly performed is microsurgical breast reconstruction. With the widening indications for multiple and “stacked” free flaps to reconstruct breasts, we endeavored to assess (1) the relationship between duration of microsurgical breast reconstruction and VTE; and (2) determine if a threshold operative time exists that connotes VTE higher risk.

Methods Patients from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) between 2005 and 2014 who underwent microsurgical breast reconstruction were identified by Current Procedural Terminology code. Three models of multivariate logistic regression were used to characterize the adjusted risk for VTE by operative duration, bilaterality, the length of stay, and patient demographics.

Results A total of 4,782 patients who underwent microsurgical breast reconstruction were identified. Overall VTE incidence was 1.13%. The mean operative duration was 8:31 hours:minutes (standard deviation: 2:59). Operative duration was statistically associated with VTE in continuous, quintile, and dichotomized risk models. Beyond an operative duration of 11 hours, adjusted VTE risk increases fourfold corresponding to a number needed to harm of 45.8.

Conclusions Increasing surgical duration heightens the risk of VTE in microsurgical breast reconstruction. Increasing body mass index and age enhances this VTE risk. Moreover, limiting surgical duration to 11 hours or less can decrease VTE risk by fourfold vis-à-vis baseline.

Level of Evidence Risk, II.

Keywords

surgical duration - venous thromboembolism - breast reconstruction

• References

• 1 Albornoz CR, Cordeiro PG, Mehrara BJ. , et al. Economic implications of recent trends in U.S. immediate autologous breast reconstruction. Plast Reconstr Surg 2014; 133 (03) 463-470
• 2 Cemal Y, Albornoz CR, Disa JJ. , et al. A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 2013; 131 (03) 320e-326e
• 3 Sbitany H, Wang F, Peled AW. , et al. Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg 2014; 134 (03) 396-404
• 4 Wang F, Koltz PF, Sbitany H. Lessons learned from the American College of Surgeons National Surgical Quality Improvement Program Database: has centralized data collection improved immediate breast reconstruction outcomes and safety?. Plast Reconstr Surg 2014; 134 (05) 859-868
• 5 Grover R, Padula WV, Van Vliet M, Ridgway EB. Comparing five alternative methods of breast reconstruction surgery: a cost-effectiveness analysis. Plast Reconstr Surg 2013; 132 (05) 709e-723e
• 6 Matros E, Albornoz CR, Razdan SN. , et al. Cost-effectiveness analysis of implants versus autologous perforator flaps using the BREAST-Q. Plast Reconstr Surg 2015; 135 (04) 937-946
• 7 Razdan SN, Cordeiro PG, Albornoz CR. , et al. Cost- effectiveness analysis of breast reconstruction options in the setting of postmastectomy radiotherapy using the BREAST-Q. Plast Reconstr Surg 2016; 137 (03) 510e-517e
• 8 Office of the Surgeon General (US); National Heart, Lung, and Blood Institute (US). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD: Office of the Surgeon General (US); 2008
• 9 Pannucci CJ, Bailey SH, Dreszer G. , et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg 2011; 212 (01) 105-112
• 10 Pannucci CJ, MacDonald JK, Ariyan S. , et al. Benefits and risks of prophylaxis for deep venous thrombosis and pulmonary embolus in plastic surgery: a systematic review and meta-analysis of controlled trials and consensus conference. Plast Reconstr Surg 2016; 137 (02) 709-730
• 11 Ricci JA, Crawford K, Ho OA, Lee BT, Patel KM, Iorio ML. Practical guidelines for venous thromboembolism prophylaxis in free tissue transfer. Plast Reconstr Surg 2016; 138 (05) 1120-1131
• 12 Pannucci CJ. Evidence- based recipes for venous thromboembolism prophylaxis: a practical safety guide. Plast Reconstr Surg 2017; 139 (02) 520e-532e
• 13 Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38 (02) (Suppl. 05) 12-19
• 14 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2-3): 70-78
• 15 Kim JY, Khavanin N, Rambachan A. , et al. Surgical duration and risk of venous thromboembolism. JAMA Surg 2015; 150 (02) 110-117
• 16 American College of Surgeons National Surgical Quality Improvement Program. User guide for the 2014 ACS NSQIP participant use data file (PUF) 2015. Available at: https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_userguide_2014.ashx . Accessed July 11, 2016.
• 17 Shiloach M, Frencher Jr SK, Steeger JE. , et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg 2010; 210 (01) 6-16
• 18 Fischer JP, Wes AM, Tuggle CT. , et al. Mastectomy with or without immediate implant reconstruction has similar 30-day perioperative outcomes. J Plast Reconstr Aesthet Surg 2014; 67 (11) 1515-1522
• 19 Kim JY, Khavanin N, Jordan SW. , et al. Individualized risk of surgical-site infection: an application of the breast reconstruction risk assessment score. Plast Reconstr Surg 2014; 134 (03) 351e-362e
• 20 Williams BA, Mandrekar JN, Mandrekar SJ, Cha SS, Furth AF. Finding optimal cutpoints for continuous covariates with binary and time-to-event outcomes. Mayo Clinic Department of Health Sciences Research, Technical Report Series #79; June 2006. Available at: http://www.mayo.edu/research/documents/biostat-79pdf/doc-10027230 . Accessed October 17, 2016
• 21 Comfere T, Sprung J, Kumar MM. , et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100 (03) 636-644
• 22 Hilsenbeck SG, Clark GM. Practical p-value adjustment for optimally selected cutpoints. Stat Med 1996; 15 (01) 103-112
• 23 McDonald JH. Chi-square test of independence. Handbook of Biological Statistics. 3rd ed. Baltimore, MD: Sparky House Publishing; 2014: 59-67
• 24 Thabane L, Mbuagbaw L, Zhang S. , et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol 2013; 13: 92
• 25 Lee PH. Is a cutoff of 10% appropriate for the change-in-estimate criterion of confounder identification?. J Epidemiol 2014; 24 (02) 161-167
• 26 Kahn SR, Shbaklo H, Lamping DL. , et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6 (07) 1105-1112
• 27 Elting LS, Escalante CP, Cooksley C. , et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med 2004; 164 (15) 1653-1661
• 28 Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J. The Incidence and economic burden of in-hospital venous thromboembolism in the United States. J Arthroplasty 2017; 32 (04) 1063-1066
• 29 Lemaine V, McCarthy C, Kaplan K. , et al. Venous thromboembolism following microsurgical breast reconstruction: an objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis. Plast Reconstr Surg 2011; 127 (04) 1399-1406
• 30 Ashjian P, Chen CM, Pusic A, Disa JJ, Cordeiro PG, Mehrara BJ. The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg 2007; 59 (01) 36-39 , discussion 39–40
• 31 Pannucci CJ, Dreszer G, Wachtman CF. , et al. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg 2011; 128 (05) 1093-1103
• 32 Rao S, Stolle EC, Sher S, Lin CW, Momen B, Nahabedian MY. A multiple logistic regression analysis of complications following microsurgical breast reconstruction. Gland Surg 2014; 3 (04) 226-231
• 33 Masoomi H, Paydar KZ, Wirth GA, Aly A, Kobayashi MR, Evans GR. Predictive risk factors of venous thromboembolism in autologous breast reconstruction surgery. Ann Plast Surg 2014; 72 (01) 30-33
• 34 Tran BH, Nguyen TJ, Hwang BH. , et al. Risk factors associated with venous thromboembolism in 49,028 mastectomy patients. Breast 2013; 22 (04) 444-448
• 35 Nwaogu I, Yan Y, Margenthaler JA, Myckatyn TM. Venous thromboembolism after breast reconstruction in patients undergoing breast surgery: An American College of Surgeons NSQIP analysis. J Am Coll Surg 2015; 220 (05) 886-893
• 36 Fischer JP, Wes AM, Tuggle CT, Wu LC. Venous thromboembolism risk in mastectomy and immediate breast reconstruction: analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program data sets. Plast Reconstr Surg 2014; 133 (03) 263e-273e
• 37 Canizares O, Mayo J, Soto E, Allen RJ, Sadeghi A. Optimizing efficiency in deep inferior epigastric perforator flap breast reconstruction. Ann Plast Surg 2015; 75 (02) 186-192
• 38 Kaplan JL, Allen RJ. Cost-based comparison between perforator flaps and TRAM flaps for breast reconstruction. Plast Reconstr Surg 2000; 105 (03) 943-948
• 39 Pannucci CJ, Chang EY, Wilkins EG. Venous thromboembolic disease in autogenous breast reconstruction. Ann Plast Surg 2009; 63 (01) 34-38
• 40 Cooney CM, Sebai ME, Ogbuagu O, Devulapalli C, Manahan MA, Rosson GD. Matching procedures at the time of immediate breast reconstruction: An American College of Surgeons National Surgical Quality Improvement Program Study of 24,191 patients. Plast Reconstr Surg 2016; 138 (06) 959e-968e
• 41 Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost 2017; 117 (02) 219-230
• 42 Pannucci CJ, Kovach SJ, Cuker A. Microsurgery and the hypercoagulable state: a hematologist's perspective. Plast Reconstr Surg 2015; 136 (04) 545e-552e
• 43 Craig ES, Walker ME, Fusi S. Venous thromboembolism risk factors in breast cancer patients undergoing deep inferior epigastric perforator flap reconstruction. Microsurgery 2012; 32 (04) 334-335
• 44 Wade RG, Marongiu F, Sassoon EM, Haywood RM, Ali RS, Figus A. Contralateral breast symmetrisation in unilateral DIEP flap breast reconstruction. J Plast Reconstr Aesthet Surg 2016; 69 (10) 1363-1373
• 45 Gosseringer N, Mani M, Cali-Cassi L, Papadopoulou A, Rodriguez-Lorenzo A. Benefits of two or more senior microsurgeons operating simultaneously in microsurgical breast reconstruction: Experience in a Swedish medical center. Microsurgery 2017; 37 (05) 416-420
• 46 Smit JM, Dimopoulou A, Liss AG. , et al. Preoperative CT angiography reduces surgery time in perforator flap reconstruction. J Plast Reconstr Aesthet Surg 2009; 62 (09) 1112-1117
• 47 Tong WM, Dixon R, Ekis H, Halvorson EG. The impact of preoperative CT angiography on breast reconstruction with abdominal perforator flaps. Ann Plast Surg 2012; 68 (05) 525-530
• 48 Ohkuma R, Mohan R, Baltodano PA. , et al. Abdominally based free flap planning in breast reconstruction with computed tomographic angiography: systematic review and meta-analysis. Plast Reconstr Surg 2014; 133 (03) 483-494
• 49 Casey III WJ, Chew RT, Rebecca AM, Smith AA, Collins JM, Pockaj BA. Advantages of preoperative computed tomography in deep inferior epigastric artery perforator flap breast reconstruction. Plast Reconstr Surg 2009; 123 (04) 1148-1155
• 50 Weichman KE, Lam G, Wilson SC. , et al. The impact of two operating surgeons on microsurgical breast reconstruction. Plast Reconstr Surg 2017; 139 (02) 277-284
• 51 Bauermeister AJ, Zuriarrain A, Newman M, Earle SA, Medina III MA. Impact of continuous two-team approach in autologous breast reconstruction. J Reconstr Microsurg 2017; 33 (04) 298-304
• 52 Hultman CS, Kim S, Lee CN. , et al. Implementation and analysis of a lean six sigma program in microsurgery to improve operative throughput in perforator flap breast reconstruction. Ann Plast Surg 2016; 76 (Suppl. 04) S352-S356
• 53 Sweetland S, Green J, Liu B. , et al; Million Women Study collaborators. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; 339: b4583
• 54 Kim EK, Eom JS, Ahn SH, Son BH, Lee TJ. The efficacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM flap. Plast Reconstr Surg 2009; 123 (01) 9-12
• 55 Keith JN, Chong TW, Davar D, Moore AG, Morris A, Gimbel ML. The timing of preoperative prophylactic low-molecular-weight heparin administration in breast reconstruction. Plast Reconstr Surg 2013; 132 (02) 279-284
• 56 Liao EC, Taghinia AH, Nguyen LP, Yueh JH, May Jr JW, Orgill DP. Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg 2008; 121 (04) 1101-1107
• 57 Koch CG, Li L, Hixson E, Tang A, Phillips S, Henderson JM. What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. J Am Coll Surg 2012; 214 (05) 798-805